Product Information
LYN-1604 is a small-molecule drug that is a potential drug target for cancer therapy. It has been shown to inhibit autophagy and induce apoptosis in cancer cells, including breast cancer tissues. LYN-1604 binds to the rapamycin complex in the cytoplasm and inhibits mTORC1 activity, which results in reduced protein synthesis and induction of autophagy. This compound also has an antitumor effect on corneal epithelium and cancer tissues.
Chemical properties
Technical inquiry about: 3D-NID93999 LYN-1604
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.